|国家科技期刊平台
首页|期刊导航|吉林大学学报(医学版)|丹参酮ⅡA磺酸钠对尿毒症毒素作用下人脐静脉内皮细胞功能的影响

丹参酮ⅡA磺酸钠对尿毒症毒素作用下人脐静脉内皮细胞功能的影响OA北大核心CSTPCD

Effect of tanshinone ⅡA on function of human umbilical vein endothelial cells after treated with uremic toxin

中文摘要英文摘要

目的:探讨丹参酮ⅡA 磺酸钠(STS)对尿毒症毒素作用下人脐静脉内皮细胞(hUVECs)功能的影响,并阐明其作用机制.方法:将hUVECs进行传代培养并分为空白对照组、尿毒症毒素刺激组、尿毒症毒素+STS组和尿毒症毒素+STS+细胞外信号调节激酶(ERK)抑制剂组,其中后2组中STS的浓度为10 mg·L-1;先给予各组剪切力刺激,剪切力大小为12 dyn·cm-2;采用CCK-8法测定各组细胞增殖活性,Western blotting法检测各组细胞中ERK、核因子κB(NF-κB)和Ⅰ型胶原蛋白表达水平,实时荧光定量PCR(RT-qPCR)法检测细胞中ERK、NF-κB和Ⅰ型胶原mRNA表达情况;原位末端转移酶标记技术(TUNEL)法检测各组细胞凋亡率.结果:CCK-8法检测,在剪切力作用后,尿毒症毒素刺激组和尿毒症毒素+STS+ERK抑制剂组细胞增殖活性低于尿毒症毒素+STS组(P<0.01).Western blotting法检测,与尿毒症毒素组比较,尿毒症毒素+STS组细胞中ERK、NF-κB和Ⅰ型胶原蛋白表达水平升高(P<0.01);抑制ERK信号通路后,与空白对照组、尿毒症毒素组和尿毒症毒素+STS组比较,尿毒症毒素+STS+ERK抑制剂组细胞中ERK、NF-κB和Ⅰ型胶原蛋白表达水平明显降低(P<0.01).RT-qPCR法检测,与尿毒症毒素组比较,尿毒症毒素+STS组细胞中ERK、NF-κB和Ⅰ型胶原mRNA表达水平升高(P<0.01);抑制ERK通路后,与空白对照组、尿毒症毒素组和尿毒症毒素+STS组比较,尿毒症毒素+STS+ERK抑制剂组细胞中ERK、NF-κB和Ⅰ型胶原mRNA表达水平明显降低(P<0.01).TUNEL法检测,尿毒症毒素+STS组的细胞凋亡率小于尿毒症毒素刺激组和尿毒症毒素+STS+ERK抑制剂组(P<0.05).结论:一定浓度STS能通过ERK信号通路调节NF-κB和Ⅰ型胶原mRNA及蛋白表达来改善尿毒症毒素作用下的内皮细胞增殖,减少细胞凋亡.

Objective:To discuss the effect of sodium tanshinone ⅡA sulfonate(STS)on the function of human umbilical vein endothelial cells(hUVECs)after treated with uremic toxin,and to clarify its mechanism.Methods:The hUVECs were passaged and divided into blank control group,uremic toxin-stimulation group,uremic toxin + STS group,and uremic toxin + STS + extracellular signal-regulated kinase(ERK)inhibitor group.The concentration of STS used in the last two groups was 10 mg·L-1.The shear stress stimulation at 12 dyn·cm-2 was applied to the cells in various groups.The proliferation activities of the cells in various groups were detected by CCK-8 assay;the expression levels of ERK,nuclear factor kappa B(NF-κB),and type Ⅰ collagen proteins in the cells in various groups were detected by Western blotting method;the expression levels of ERK,NF-κB,and type Ⅰ collagen mRNA in the cells in various groups were detected by real-time fluorescence quantitative PCR(RT-qPCR)method;the apoptotic rates the cells in various groups were detected by TUNEL method.Results:The CCK-8 assay results showed that after treated with shear stress,the probiferation activitres of the cells in uremic toxin-stimulation group and uremic toxin + STS + ERK inhibitor group were lower than that in uremic toxin + STS group(P<0.01).The Western blotting results showed that compared with uremic toxin group,the expression levels of ERK,NF-κB,and type Ⅰ collagen proteins in the cells in uremic toxin + STS group were increased(P<0.01).After inhibiting the ERK pathway,compared with blank control group,uremic toxin group,and uremic toxin + STS group,the expression levels of ERK,NF-κB,and type Ⅰ collagen proteins in the cells in uremic toxin + STS + ERK inhibitor group were significantly decreased(P<0.01).The RT-qPCR results showed that compared with uremic toxin group,the expression levels of ERK,NF-κB,and type Ⅰ collagen mRNA in the cells in uremic toxin + STS group were increased(P<0.01).After inhibiting the ERK signaling pathway,compared with blank control group,uremic toxin group,and uremic toxin + STS group,the expression levels of ERK,NF-κB,and type Ⅰ collagen mRNA in the cells in uremic toxin + STS + ERK inhibitor group were significantly decreased(P<0.01).The TUNEL method detection results showed that the apoptotic rate in the cells in uremic toxin + STS group was lower than those in uremic toxin-stimulation group and uremic toxin + STS + ERK inhibitor group(P<0.05).Conclusion:A certain concentration of STS can improve the proliferation of the endothelial cells and reduce the apoptosis of the cells after treated with uremic toxins by modulating the expressions of NF-κB and type Ⅰ collagen mRNA and proteins through the ERK signaling pathway.

王立华;贾岚;陈海燕;杨波;王喆;毕学青

天津医科大学第二医院肾脏病血液净化科,天津 300211天津中医药大学第一附属医院肾内科,天津 301617

临床医学

血液透析动静脉内瘘人脐静脉内皮细胞尿毒症丹参酮ⅡA磺酸钠

HemodialysisArterial-venous fistulaHuman umbilical vein endothelial cellUremiaSodium tanshinone ⅡA sulphonase

《吉林大学学报(医学版)》 2024 (002)

364-370 / 7

天津市卫健委中医中西医结合项目(2021173)

10.13481/j.1671-587X.20240209

评论